Point72 (Difc) LTD Ocugen, Inc. Transaction History
Point72 (Difc) LTD
- $2.64 Trillion
- Q2 2025
A detailed history of Point72 (Difc) LTD transactions in Ocugen, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 16,868 shares of OCGN stock, worth $29,856. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,868Holding current value
$29,856% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OCGN
# of Institutions
112Shares Held
64.6MCall Options Held
604KPut Options Held
253K-
Black Rock Inc. New York, NY17.9MShares$31.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.8MShares$26.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.06MShares$8.95 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$7.35 Million0.17% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$6.17 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $383M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...